These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52. Assessment of Anti-Tissue Type Plasminogen Activator Antibodies in Patients With Prosthetic Heart Valve Thrombosis: The ATA Trial. Özkan M; Kalçık M; Gürsoy MO; Öcal L; Griffini S; Karakoyun S; Yesin M; Gündüz S; Astarcıoğlu MA; Bayam E; Cerşit S; Aykan AÇ; Cugno M J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):372-80. PubMed ID: 26657322 [TBL] [Abstract][Full Text] [Related]
53. Pulsed high-intensity focused ultrasound enhances thrombolysis in an in vitro model. Frenkel V; Oberoi J; Stone MJ; Park M; Deng C; Wood BJ; Neeman Z; Horne M; Li KC Radiology; 2006 Apr; 239(1):86-93. PubMed ID: 16493016 [TBL] [Abstract][Full Text] [Related]
54. Vasospasm prevention with postoperative intrathecal thrombolytic therapy: a retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone. Usui M; Saito N; Hoya K; Todo T Neurosurgery; 1994 Feb; 34(2):235-44; discussion 244-5. PubMed ID: 8177383 [TBL] [Abstract][Full Text] [Related]
55. Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue plasminogen activator in the rabbit. Marder VJ; Landskroner K; Novokhatny V; Zimmerman TP; Kong M; Kanouse JJ; Jesmok G Thromb Haemost; 2001 Sep; 86(3):739-45. PubMed ID: 11583303 [TBL] [Abstract][Full Text] [Related]
56. Safety and efficacy of ultrasound-enhanced thrombolysis: a comprehensive review and meta-analysis of randomized and nonrandomized studies. Tsivgoulis G; Eggers J; Ribo M; Perren F; Saqqur M; Rubiera M; Sergentanis TN; Vadikolias K; Larrue V; Molina CA; Alexandrov AV Stroke; 2010 Feb; 41(2):280-7. PubMed ID: 20044531 [TBL] [Abstract][Full Text] [Related]
57. Endothelial dysfunction after arterial thrombosis is ameliorated by L-arginine in combination with thrombolysis. Davis MR; Ortegon DP; Kerby JD; Ignarro LJ; Kashyap VS J Vasc Interv Radiol; 2003 Feb; 14(2 Pt 1):233-9. PubMed ID: 12582192 [TBL] [Abstract][Full Text] [Related]
58. Local thrombolysis with recombinant tissue plasminogen activator in a high-risk patient. Baudo F; Brambilla G; deCataldo F; Rampoldi A Lancet; 1993 Jan; 341(8836):64. PubMed ID: 8093321 [No Abstract] [Full Text] [Related]
59. Thrombolysis in Real Time: Demonstration of Revascularization with Intravenous Thrombolysis Therapy in the CT Scanner. Tan J; Aysenne A; Singh V J Neuroimaging; 2017 Jan; 27(1):50-58. PubMed ID: 27653945 [TBL] [Abstract][Full Text] [Related]
60. Quantitative Imaging of Cerebral Thromboemboli In Vivo: The Effects of Tissue-Type Plasminogen Activator. Kim DE; Kim JY; Schellingerhout D; Ryu JH; Lee SK; Jeon S; Lee JS; Kim J; Jang HJ; Park JE; Kim EJ; Kwon IC; Ahn CH; Nahrendorf M; Kim K Stroke; 2017 May; 48(5):1376-1385. PubMed ID: 28432262 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]